In a transfer, registered at the country’s Central Depository on November 26, Telso sold 35,000 shares in the drug maker, Sopharma said in a statement to the Sofia bourse.
The value or parties to the deal were not disclosed.
Blue chip Sopharma was traded 0.41% higher at 2.209 levs ($1.46/1.13 euro) on the Bulgarian Stock Exchange by 1305 GMT on Monday.
(1 euro=1.95583 Bulgarian levs)